Skip Navigation

Phase II Pediatric Study With Dabrafenib in Combination With Trametinib in Patients With HGG and LGG

Brief Summary

Type:
Brain Tumors / Neurologic Cancers

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT02684058

Study #:
CMH - CDRB436G2201

Start Date:
Mar 14, 2018

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02684058

View Complete Trial Details & Eligibility at ClinicalTrials.gov